Burford Capital Logo Light Burford Capital Logo Dark

Financed corporate IP monetization

For pharma and life sciences companies seeking to extract value from their IP, it’s imperative that they understand the sophistication of financial structures currently available to them. In all likelihood, they’re sitting on millions; legal finance can help them access it.

Capital provision

Burford can provide finance acquisition capital for the initial patent purchase, funding for the legal fees and costs to be incurred as part of the future monetization strategy and working capital for the new patent owner’s entity


Process facilitation

Burford can work directly with prospective bidders to evaluate monetization potential 


Resource access

Burford can introduce experienced legal counsel and other monetization resources to a potential buyer, enhancing the prospects of future success


Sale stability

Burford can provide assurance that an agreed transaction won’t fall apart due to lack of capital


Transaction confidentiality

Burford can provide a private transaction that can be structured in repeatable parts to smooth revenue over a longer financial period 

32,000

The number of patents BlackBerry sold in 2023

$900M

Potential transaction value of BlackBerry’s $170 million sale

Intel, ATT & more

The list of corporate patent sellers also includes Intel, ATT, HP, HPE, Huawei, NEC, Pioneer Corporation and Siemens Healthineers